G1 Therapeutics to Present at 35th Annual J.P. Morgan Healthcare Conference
Jan 03, 2017 13:00 pm UTC| Business
RESEARCH TRIANGLE PARK, N.C., Jan. 03, 2017 -- G1 Therapeutics, Inc., a clinical-stage oncology company, announced today that Chief Executive Officer Mark Velleca, MD, PhD, will present a company overview at the 35th...
Aclaris to Present at 35th Annual J.P. Morgan Healthcare Conference
Jan 03, 2017 13:00 pm UTC| Business
MALVERN, Pa., Jan. 03, 2017 -- Aclaris Therapeutics, Inc.(NASDAQ:ACRS), a dermatologist-led clinical-stage pharmaceutical company focused on defining new standards of care in medical and aesthetic dermatology, today...
Jan 03, 2017 13:00 pm UTC| Business
CAMBRIDGE, Mass., Jan. 03, 2017 -- Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that Craig Wheeler,...
FTD Companies, Inc. to Present at 19th Annual ICR Conference
Jan 03, 2017 13:00 pm UTC| Business
DOWNERS GROVE, Ill., Jan. 03, 2017 -- FTD Companies, Inc. (Nasdaq:FTD) (“FTD” or the “Company”), a premier floral and gifting company, today announced that interim President and Chief Executive Officer, Christopher W....
Wingstop Inc. Announces Appointment of New Independent Board Member
Jan 03, 2017 13:00 pm UTC| Business
DALLAS, Jan. 03, 2017 -- Wingstop Inc. (NASDAQ:WING), the award-winning wing concept with more than 900 locations worldwide, today announced the appointment of seasoned public company director and former McDonald’s...
Portola Pharmaceuticals to Webcast Corporate Update on January 10, 2017
Jan 03, 2017 13:00 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Jan. 03, 2017 -- Portola Pharmaceuticals, Inc.® (Nasdaq:PTLA) today announced that it will host an investor webcast to review recent achievements and corporate and product milestones over...
Acne Vulgaris Forecast in 15 Major Markets 2016 - 10 Year Snapshot to 2026
Jan 03, 2017 12:31 pm UTC| Business
Dublin, Jan. 03, 2017 -- Research and Markets has announced the addition of the "Acne Vulgaris Forecast in 15 Major Markets 2016-2026" report to their offering. This report...